FDA: Tomatoes Recalled Over Salmonella Concerns in 14 States
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links."
The U.S. Food and Drug Administration says that Ray & Mascari Inc. has issued a recall of its Four-Count Vine Ripe Tomatoes that were sold across 11 U.S. states.
The voluntary recall was issued on May 2, after the company was made aware of a possible Salmonella contamination at the facility charged with repackaging the tomatoes for distribution.
Williams Farms Repack LLC also recently recalled tomatoes in three states.
You can find out which lots were included in the recall below.
Fresh tomatoes are key for some of our favorite recipes—they liven up a garden salad and are the main show in salsa. But you may want to double-check your next bunch before purchasing. Ray & Mascari Inc. issued a recall of its vine-ripened tomatoes in 11 states, according to the U.S. Food and Drug Administration (FDA).
According to the FDA statement, the company is specifically recalling its Four-Count Vine Ripe Tomatoes, which were packed in clear 20-oz clamshell containers that featured the UPC# 7 96553 20062 1.
The packages also came with a master case label that included either Lot# RM250424 15250B or Lot# RM250427 15250B. These tomatoes were sold by Gordon Food Service Stores located in the following states:
Illinois
Indiana
Kentucky
Michigan
Missouri
Mississippi
New York
Ohio
Pennsylvania
Tennessee
Wisconsin
The company decided to recall the product after receiving word that Florida-based Hanshaw & Capling Farms decided to recall the Ray & Mascari Inc. tomatoes that were repackaged in its facility after Hanshaw & Capling Farms was made aware of the possible presence of Salmonella. Ray & Mascari Inc. then notified its customers and distributors, providing them with the recall instructions to be shared with the retail customers who may have bought the potentially contaminated goods.
The FDA statement noted that customers who have purchased the recalled tomatoes should discontinue using them at once. Anyone with any questions should call Ray & Mascari Inc. during regular business hours, Monday through Saturday, from 6 a.m. to 5 p.m. EST.
Salmonella can be dangerous, according to the Mayo Clinic. Symptoms may include diarrhea, abdominal cramping, and fever. In extreme cases, severe dehydration can occur, requiring medical attention. The very young, very old, and those with a weakened immune system are most at risk for severe complications, which can happen when the bacteria spread beyond the intestines and may result in serious complications.
Otherwise, the Mayo Clinic notes that most people will see symptoms resolve on their own in a week to 10 days. In some cases, people may experience lingering digestive issues, which may continue for months after the rest of the symptoms resolve.
As of press time, there haven't been any illnesses reported as a result of this recall.
But it's not the only tomato recall to note. Williams Farms Repack LLC is another, recalling tomatoes sold to wholesalers in South Carolina, North Carolina, and Georgia, distributed in April, the FDA said in a separate notice. Specifically, its 4x5 two-layer, 60ct two-layer, 3ct trays in the Williams Farms Repack label, and 5x6 25lb, 6x6 25lb H&C Farms Label, are impacted.
You Might Also Like
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Rochester-based organization providing aid to Haiti reacts to international travel ban
ROCHESTER, N.Y. (WROC) – The Trump administration has imposed a travel ban on 12 countries, which took effect Monday. The ban is prohibiting those primarily in Africa and the Middle East from entering the U.S. out of concerns of national security and terrorism. Haiti is among the countries affected. News 8 spoke to the leader of one local organization overseeing mission work there for years. Dr. Ralph Pennino co-founded Intervol in the late 80s and for more than three decades, the Rochester-based organization has helped to provide countless medical supplies and equipment in developing countries each year. In 2017, Dr. Pennino helped to create a school in Leogane, Haiti, which is not far from the country's capital of Port-Au-Prince. 'Right now, we've got grades 1 through 9. These are kids that wouldn't have a choice in education otherwise,' said Dr. Pennino. Regarding the travel ban, Dr. Pennino says the future of volunteerism is unclear. With a population plagued by poverty and violence, he says it only makes matters more complicated. 'Haiti, interestingly enough, has the highest number of volunteers per capita for a population that comes down to try and help Haiti. To be quite honest, there's probably going to be a lot of repair work to do because people are going to be afraid. And I understand. They're not going to go want to go there,' said Dr. Pennino. Catholic Charities closing certain refugee resettlement programs While there's no immediate answer as to when the travel ban will lift, Intervol continues to meet with students online for services like medical checkups or educational lessons. 'We'd normally send doctors down that would go to some of the remote villages to do primary care and the surgeons would go to part of the hospital. That part of what we do, I don't know how long it's going to be,' said Dr. Pennino. Dr. Pennino added for the first time in the Haitian school's history, their ninth graders are about to complete their national exams. He says that has been a positive in the midst of uncertainty. More information on ways to donate or help support Intervol's cause in Haiti can be found here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Yahoo
39 minutes ago
- Yahoo
Prime Healthcare cutting about 100 jobs across its Illinois facilities, months after acquiring hospitals from Ascension
Prime Healthcare, which bought eight Illinois hospitals earlier this year, is eliminating more than 100 jobs, the hospital system confirmed Monday. Prime made most of the reductions Friday, and will continue cutting other jobs through July. 'As we continue to offer and create opportunities, we are also evaluating alignment with best practices and support from our national and regional teams,' Prime said in a statement. 'Through this process, there is a small number of positions that are duplicated or not aligned with the care model and service line offerings — most of them not directly providing patient care — that will be consolidated.' None of the affected jobs are union positions, according to Prime. Prime hired 13,000 workers from Ascension when it bought the hospitals from that health system, and has created nearly 1,000 new jobs since the acquisition. The job cuts represent less than 1% of the combined 14,000 employees, according to the statement. 'Importantly, these efforts will not affect the quality of care we deliver to the communities we serve and in fact will help expand best practices from across the nation,' Prime said in the statement. 'All decisions made at our Illinois facilities are guided by our mission to improve quality, strengthen care delivery, preserve access in underserved areas and ensure long-term sustainability.' The California-based Prime bought the Illinois hospitals for more than $370 million in March. Six of the hospitals sold to Prime changed from being nonprofit hospitals to for-profit hospitals as part of the sale. Hospitals that were sold include St. Mary's Hospital in Kankakee, Holy Family Medical Center in Des Plaines, Resurrection Medical Center in Chicago, St. Francis Hospital in Evanston, St. Joseph Medical Center in Joliet, St. Joseph Hospital in Elgin, Mercy Medical Center in Aurora and St. Mary of Nazareth Hospital in Chicago. The job cuts are the latest in a string of changes Prime has made since closing the deal, drawing criticism from elected officials and a nurses union. Prime announced in April that it planned to suspend inpatient pediatric care at St. Joseph Medical Center in Joliet, saying at the time that the unit had been averaging less than one patient a day, while the need for other services such as advanced surgical, neurosurgical and spinal care had grown. The Illinois Nurses Association condemned the move, arguing it would hurt the community, which only has one hospital. Also, Mercy Medical Center in Aurora lost its designation in April as a Level II trauma center. Prime also suspended obstetrical services at St. Mary's in Kankakee after the hospital's 'nearly sole obstetrics physician' retired, and because of low demand, Prime has said. Sens. Dick Durbin and Tammy Duckworth sent a letter to Prime's chairman, founder and CEO Dr. Prem Reddy in May expressing concern about those changes and asking Prime to elaborate on the reasons behind them and its future plans for the hospitals. Prime responded to that letter last week, emphasizing its mission of turning around struggling community hospitals across the country. Prime said that before it bought the hospitals in Illinois they were losing about $200 million a year. Prime said maintaining services with low patient demand is not sustainable, nor good for the quality of care. Prime also told the senators it plans to expand behavioral health care services for seniors at its Illinois facilities. In its statement Monday, Prime said it has started fulfilling a previously stated commitment to invest $250 million across the Illinois hospitals. Prime said those affected by the job cuts are invited to apply for any of the more than 900 open positions across its Illinois facilities. The job cuts were first reported by the Herald News.
Yahoo
an hour ago
- Yahoo
Innerbody Labs Testosterone Support Announces Official Website Update Featuring Natural Daily Supplement for Men's Health and Vitality
Updated Product Page Now Highlights Daily Testosterone Support Formula for Adult Men Seeking Natural Energy, Vitality, and Wellness Backed by Research PALO ALTO, June 09, 2025 (GLOBE NEWSWIRE) -- Innerbody Testosterone Support, a California-based wellness brand developed by Innerbody Research, Inc., has updated its official website to highlight a daily supplement designed to support testosterone health, energy, and physical performance in adult men. Available nationwide, the formula is intended for individuals seeking a natural, consistent addition to their wellness routines. According to the official product page ( Innerbody Testosterone Support works in concert with the body's internal systems to help maintain healthy testosterone levels associated with vitality, stamina, and overall wellness. The product is positioned as a clean, once-daily supplement made for modern lifestyles—no complicated regimens or restrictive dietary requirements. 'We believe that supporting your health should be simple, effective, and transparent,' said a company representative. 'Our testosterone support formula reflects that philosophy and our commitment to natural wellness backed by science.' Innerbody Research, Inc. confirms that its supplements are manufactured in facilities following rigorous quality assurance protocols. The product is composed of carefully selected ingredients that align with common goals for adult male wellness, such as hormone balance, muscle support, and natural energy maintenance. As shared on the website, the product includes a satisfaction guarantee for new customers. Additional product details, usage insights, and ordering options are available at the official site. About Innerbody Testosterone Support Innerbody Testosterone Support is part of Innerbody Research, Inc., a wellness brand based in Palo Alto, California, focused on delivering research-informed supplements that promote health and longevity. The brand emphasizes transparency, natural formulation, and ease of use to help adults support their wellness goals through daily routines. Product and Contact Information Brand: Innerbody Testosterone SupportWebsite: support@ +1 (650) 456-2677Mailing Address: Innerbody Research, Inc.3790 El Camino Real, Unit 524Palo Alto, CA 94306 Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The statements made about this product have not been evaluated by the Food and Drug Administration. Individual results may vary. Consumers should consult a qualified healthcare provider before beginning any new dietary supplement. CONTACT: Email: support@ Phone: +1 (650) 456-2677